HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L’Oréal North American Sales Driven By Three Business Divisions

This article was originally published in The Rose Sheet

Executive Summary

L'Oréal 8.1% like-for-like sales growth in North America for the year and 9% growth in the fourth quarter was fueled by market share gains within three of the French firm's business units, Professional, Consumer and Luxury Products, the company reported Jan. 26

You may also be interested in...



L’Oréal Records 2004 Double-Digit Profit On Cost Restraints

L'Oréal's operating profit grew16.3% to $2.77 bil. (€1=$1.30) in 2004, despite the negative effect of currency fluctuations, the firm reported during a Feb. 17 earnings call

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012786

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel